Virbac SA
VIRP
Company Profile
Business description
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.
Contact
13e rue LID - BP 27
Carros06511
FRAT: +33 492087100
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
5,620
Stocks News & Analysis
stocks
Will China strong arm BHP into lower iron ore prices?
Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
stocks
Chart of the Week: Where Morningstar sees attractive dividend yields in 26/27
Charts from the Australian Dividend Outlook show the sectors where they are abundant.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,276.60 | 19.90 | -0.21% |
| CAC 40 | 8,041.36 | 18.77 | -0.23% |
| DAX 40 | 24,611.25 | 14.12 | 0.06% |
| Dow JONES (US) | 46,290.95 | 310.83 | -0.67% |
| FTSE 100 | 9,509.40 | 39.47 | -0.41% |
| HKSE | 26,752.59 | 76.87 | -0.29% |
| NASDAQ | 22,985.24 | 58.13 | -0.25% |
| Nikkei 225 | 48,580.44 | 845.45 | 1.77% |
| NZX 50 Index | 13,570.86 | 2.38 | 0.02% |
| S&P 500 | 6,726.25 | 27.47 | -0.41% |
| S&P/ASX 200 | 8,969.80 | 25.20 | -0.28% |
| SSE Composite Index | 3,933.97 | 51.20 | 1.32% |